NEW YORK, Nov 6 (Reuters) - Shares of Par Pharmaceutical Cos rose 4.9 percent to $23.90 in premarket trading on Friday, after the company reported its third-quarter results, helped by new drug launches and limited competition against some of its key products.
For details, see
(Reporting by Ryan Vlastelica; Editing by Theodore d'Afflisio) Keywords: MARKETS STOCKS BEFORETHEBELL (ryan.vlastelica@thomsonreuters.com; Tel: +1 646-223-6014; Reuters Messaging: ryan.vlastelica@reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
For details, see
(Reporting by Ryan Vlastelica; Editing by Theodore d'Afflisio) Keywords: MARKETS STOCKS BEFORETHEBELL (ryan.vlastelica@thomsonreuters.com; Tel: +1 646-223-6014; Reuters Messaging: ryan.vlastelica@reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.